Skip to main content

Table 2 Reporting by Member States on routine surveillance of viral hepatitis B and C

From: Strengthening hepatitis B and C surveillance in Europe: results from the two global hepatitis policy surveys (2013 and 2014)

  World Health Organization European sub-region Total
  West Centre East
  N = 18 (%) N = 13 (%) N = 13 (%) N = 44 (%)
National surveillance system for acute HBV:
 yes 17 (94.4) 13 (100) 13 (100) 43 (97.3)
 no 1 (5.6) 0 (0) 0 (0) 1 (2.3)
National surveillance system for acute HCV:
 yes 15 (83.3) 13 (100) 13 (100) 41 (93.2)
 no 3 (16.7) 0 (0) 0 (0) 3 (6.8)
National surveillance system for chronic HBV:
 yes 11 (61.1) 7 (53.8) 10 (76.9) 28 (63.6)
 no 7 (38.9) 6 (46.2) 3 (23.1) 16 (36.4)
National surveillance system for chronic HCV:
 yes 10 (55.6) 7 (53.8) 10 (76.9) 27 (61.4)
 no 8 (44.4) 6 (46.2) 3 (23.1) 17 (38.6)
Standard case definitions for viral hepatitis infections:
 yes 17 (94.4) 13 (100) 12 (92.3) 42 (95.5)
 no 1 (5.6) 0 (0) 1 (7.7) 2 (4.5)
% of hepatitis cases reported as “undifferentiated” or “unclassified”:
 zero 6 (33.3) 2 (15.4) 2 (15.4) 10 (22.7)
 less than 5 % 2 (11.1) 4 (30.8) 3 (23.1) 9 (20.5)
 5–15 % 0 (0) 2 (15.4) 3 (23.1) 5 (11.4)
 more than 15 % 1 (5.6) 2 (15.4) 1 (7.1) 4 (9.1)
 no response 9 (50.0) 3 (23.1) 4 (30.8) 16 (36.4)
Adequate laboratory capacity nationally to support hepatitis outbreak investigations and other surveillance activities for HBV and HBC:
 yes 18 (100) 13 (100) 13 (100) 44 (100)
Hepatitis outbreaks required to be reported to the government and further investigated:
 yes 17 (94.4) 13 (100) 12 (92.3) 42 (95.5)
 no 1 (5.6) 0 (0) 1 (7.7) 2 (4.5)
Hepatitis disease reports published regularly (at least once per year):
 yes 15 (83.3) 13 (100) 11 (84.6) 39 (88.6)
 no 3 (16.7) 0 (0) 2 (15.4) 5 (11.4)